BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G. An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy. Clin Kidney J 2019;12:333-7. [PMID: 31198225 DOI: 10.1093/ckj/sfz040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Nitzan-Luques A, Slae M, Zugayar D, Dixon BP, Meir K, Volovelsky O. Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease. J Nephrol 2021;34:241-5. [PMID: 32514992 DOI: 10.1007/s40620-020-00766-5] [Reference Citation Analysis]
2 Jarmoliński T, Rosa M, Puziewicz-Zmonarska A, Kałwak K. Short Course of Eculizumab May Be Effective in Dialysis-Dependent Transplantation-Associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: A Case Report. Transplant Proc 2020;52:2544-7. [PMID: 32917392 DOI: 10.1016/j.transproceed.2020.08.040] [Reference Citation Analysis]
3 Rossi M, Pessolano G, Caletti C, De Biase V, Gambaro G. Mixed typical and atypical hemolytic uremic syndrome in a kidney transplant patient. J Nephrol 2021. [PMID: 34224089 DOI: 10.1007/s40620-021-01112-z] [Reference Citation Analysis]
4 Rassner M, Baur R, Wäsch R, Schiffer M, Schneider J, Mackensen A, Engelhardt M. Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma. BMC Nephrol 2021;22:32. [PMID: 33461512 DOI: 10.1186/s12882-020-02226-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Allinovi M, Bellinvia A, Pesce F, Milan Manani S, Razzolini L, Brezzi B, Protopapa P, Mantero V, Caroti L, Cirami CL, Amato MP, Del Vecchio L. Safety and Efficacy of Eculizumab Therapy in Multiple Sclerosis: A Case Series. Brain Sci 2021;11:1341. [PMID: 34679405 DOI: 10.3390/brainsci11101341] [Reference Citation Analysis]
6 Ormonde C, Querido S, Rombo N, Roque R, Clemente B, Weigert A. Primary Hyperaldosteronism: A Rare Cause of Malignant Hypertension with Thrombotic Microangiopathy in a Kidney Transplant Recipient. Case Rep Transplant 2021;2021:9261371. [PMID: 34820145 DOI: 10.1155/2021/9261371] [Reference Citation Analysis]
7 Newton J, Floyd L, Ponnusamy A, Anderton J. Thrombotic microangiopathy secondary to recurrent prostate cancer. Clin Nephrol Case Stud 2021;9:105-9. [PMID: 34549020 DOI: 10.5414/CNCS110609] [Reference Citation Analysis]
8 Favaloro EJ, Henry BM, Lippi G. Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis. Semin Thromb Hemost 2021;47:400-18. [PMID: 33893632 DOI: 10.1055/s-0041-1727282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Wadehra A, Alkassis S. Atypical Hemolytic Uremic Syndrome in the Setting of Acute Clostridium difficile Colitis. Cureus 2021;13:e13244. [PMID: 33728192 DOI: 10.7759/cureus.13244] [Reference Citation Analysis]
10 Haninger-Vacariu N, Aigner C, Kain R, Prohászka Z, Gaggl M, Böhmig GA, Piggott LC, Sunder-Plassmann R, Sunder-Plassmann G, Schmidt A. Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy. Kidney Med 2020;2:213-7. [PMID: 32734241 DOI: 10.1016/j.xkme.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Aigner C, Gaggl M, Kain R, Prohászka Z, Garam N, Csuka D, Sunder-Plassmann R, Piggott LC, Haninger-Vacariu N, Schmidt A, Sunder-Plassmann G. Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy. J Clin Med 2020;9:E964. [PMID: 32244370 DOI: 10.3390/jcm9040964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Haninger-Vacariu N, Aigner C, Gaggl M, Kain R, Prohászka Z, Böhmig GA, Sunder-Plassmann R, Sunder-Plassmann G, Schmidt A. Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy. Clin Kidney J 2021;14:1255-60. [PMID: 33841869 DOI: 10.1093/ckj/sfaa113] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Nasonov EL, Reshetnyak TM, Alekberova ZS. [Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity]. Ter Arkh 2020;92:4-14. [PMID: 32598770 DOI: 10.26442/00403660.2020.05.000697] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Ranabothu S, Brown CC, Blaszak R, Millner R, Moore KR, Prodhan P. Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome. Front Pediatr 2021;9:733042. [PMID: 34676187 DOI: 10.3389/fped.2021.733042] [Reference Citation Analysis]